Search company, investor...

Predict your next investment

Government
nih.gov

Investments

911

Funds

3

Partners & Customers

10

About National Institutes of Health

The National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services, is the nation's medical research agency making important medical discoveries. It was founded in 1887 and is based in Bethesda, Maryland.

Headquarters Location

9000 Rockville Pike

Bethesda, Maryland, 20892,

United States

301-496-4000

Want to inform investors similar to National Institutes of Health about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing National Institutes of Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find National Institutes of Health in 2 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

382 items

M

Medical Devices

66 items

https://mdic.org/membership/our-members/

Latest National Institutes of Health News

Acenxion Biosystems Awarded $3 Million NIAID Grant – Acenxion Biosystems

Jun 6, 2023

Acenxion Biosystems Awarded $3 Million NIAID Grant [Kansas City, KS] Acenxion Biosystems Inc. today announced that it was awarded a $3M SBIR Direct-to-Phase II grant by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID). The award accelerates Acenxion’s work to develop the first fully automated gonorrhea phenotypic antimicrobial sensitivity testing (AST) platform. The system will simultaneously meet the CDC’s guidance for surveillance and their recommendations for clinical treatment. The CDC has long considered gonorrhea as one of the top five threats and reaffirmed that position in its 2019 Antibiotic Resistance Threats in the United States publication. “This is a significant step for our early-stage company,” said Dr. Roy Swiger, CEO. “The team has reall pulled together to deliver an exceptional technology that we highlighted in our grant proposal. The situation with antibiotic resistant gonorrhea is grave and Acenxion has a solution that can reset the playing field and turn the tables on this major public health issue,” he said. Dr. Wayne Carter, a Director for Acenxion Biosystems added, “Receipt of this grant is affirmation by NIAID of the significant advancement the Acenxion Biosystem technology is for gonorrhea surveillance and can be used for antibiotic resistance threats across the US and world. Roy and his team have worked tirelessly to deliver this innovation, which will yield untold clinical benefits.” In addition to the CDC’s 2019 report, the Interagency Coordination Group of Antimicrobial Resistance report to the UN Secretary-General, No Time to Wait: Security the Future From Drug-Resistant Infections detailed the millions of untreatable infections, resultant medical hardships, and death that occur each year and how this situation is becoming worse, making innovations like Acenxion’s extremely valuable. Acenxion Biosystems (ACXBIO) is a privately funded company developing automated systems for bacteria detection in blood cultures and phenotypic antimicrobial susceptibility testing (AST). Seamlessly fitting into current clinical workflows, Acenxion’s scalable AST system reduces the time required for phenotypic testing to just 4-6 hours, allowing clinicians rapid use of a precise, targeted treatment. Acenxion’s technology improves patient outcomes, reduces healthcare costs, and reduces the spread of antibiotic resistance extending the service life of antibiotics.

National Institutes of Health Investments

911 Investments

National Institutes of Health has made 911 investments. Their latest investment was in Domus Diagnostics as part of their Grant on May 5, 2023.

CBI Logo

National Institutes of Health Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/25/2023

Grant

Domus Diagnostics

Yes

1

5/23/2023

Grant - III

Aphios

Yes

1

5/18/2023

Grant - V

National Disease Research Interchange

$14.4M

No

2

5/17/2023

Grant - II

Subscribe to see more

$99M

Subscribe to see more

10

5/16/2023

Grant

Subscribe to see more

Subscribe to see more

10

Date

5/25/2023

5/23/2023

5/18/2023

5/17/2023

5/16/2023

Round

Grant

Grant - III

Grant - V

Grant - II

Grant

Company

Domus Diagnostics

Aphios

National Disease Research Interchange

Subscribe to see more

Subscribe to see more

Amount

$14.4M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

2

10

10

National Institutes of Health Fund History

3 Fund Histories

National Institutes of Health has 3 funds, including Dengue Grants - UO1.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Dengue Grants - UO1

1

West Nile Grant

10

Dengue Grants - UC1

10

Closing Date

Fund

Dengue Grants - UO1

West Nile Grant

Dengue Grants - UC1

Fund Type

Status

Amount

Sources

1

10

10

National Institutes of Health Partners & Customers

10 Partners and customers

National Institutes of Health has 10 strategic partners and customers. National Institutes of Health recently partnered with Maxim Biomedical on May 5, 2023.

Date

Type

Business Partner

Country

News Snippet

Sources

5/9/2023

Vendor

United States

MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform

MaximBio inks new contract with National Institutes of Health RADx to develop novel rapid home test platform

2

4/19/2023

Vendor

United States

DMI Wins Recompete Work with NIH

Worth $ 24 million over three years , the win will build on DMI 's two previous contracts with the NIH OD to provide cybersecurity modernization services .

2

12/28/2022

Vendor

United States

Peraton Awarded $1.7B to Provide IT Professional Services to National Institutes of Health's National Cancer Institute

RESTON , Va. , Dec. 28 , 2022 / PRNewswire / -- Peraton has secured a seat on a five-year , unrestricted $ 1.7 billion blanket purchase agreement to support information technology and professional IT services for the National Cancer Institute Center for Biomedical Informatics and Information Technology .

3

10/6/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

10/3/2022

Vendor

United States

Subscribe to see more

Subscribe to see more

10

Date

5/9/2023

4/19/2023

12/28/2022

10/6/2022

10/3/2022

Type

Vendor

Vendor

Vendor

Partner

Vendor

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

MaximBio Inks Contract with National Institutes of Health (RADx) Centered on a new Rapid Platform

MaximBio inks new contract with National Institutes of Health RADx to develop novel rapid home test platform

DMI Wins Recompete Work with NIH

Worth $ 24 million over three years , the win will build on DMI 's two previous contracts with the NIH OD to provide cybersecurity modernization services .

Peraton Awarded $1.7B to Provide IT Professional Services to National Institutes of Health's National Cancer Institute

RESTON , Va. , Dec. 28 , 2022 / PRNewswire / -- Peraton has secured a seat on a five-year , unrestricted $ 1.7 billion blanket purchase agreement to support information technology and professional IT services for the National Cancer Institute Center for Biomedical Informatics and Information Technology .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

2

3

10

10

National Institutes of Health Team

1 Team Member

National Institutes of Health has 1 team member, including former President, Ezekiel J. Emanuel.

Name

Work History

Title

Status

Ezekiel J. Emanuel

President

Former

Name

Ezekiel J. Emanuel

Work History

Title

President

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.